1. Home
  2. NAVI vs SPRY Comparison

NAVI vs SPRY Comparison

Compare NAVI & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Navient Corporation

NAVI

Navient Corporation

HOLD

Current Price

$9.06

Market Cap

771.2M

Sector

Finance

ML Signal

HOLD

Logo ARS Pharmaceuticals Inc.

SPRY

ARS Pharmaceuticals Inc.

HOLD

Current Price

$8.18

Market Cap

833.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NAVI
SPRY
Founded
1973
2015
Country
United States
United States
Employees
670
N/A
Industry
Investment Bankers/Brokers/Service
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
771.2M
833.1M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
NAVI
SPRY
Price
$9.06
$8.18
Analyst Decision
Sell
Strong Buy
Analyst Count
7
1
Target Price
$10.29
$40.00
AVG Volume (30 Days)
803.2K
1.4M
Earning Date
04-29-2026
05-13-2026
Dividend Yield
7.21%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$84,278,000.00
Revenue This Year
$76.23
$90.76
Revenue Next Year
$15.73
$81.70
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.80
$6.66
52 Week High
$16.07
$18.63

Technical Indicators

Market Signals
Indicator
NAVI
SPRY
Relative Strength Index (RSI) 63.25 47.22
Support Level $7.83 $8.05
Resistance Level $13.34 $8.63
Average True Range (ATR) 0.28 0.37
MACD 0.12 0.05
Stochastic Oscillator 95.73 55.36

Price Performance

Historical Comparison
NAVI
SPRY

About NAVI Navient Corporation

Navient Corp provides technology-enabled education finance solutions that simplify complex programs and help millions of people achieve success. The company operates its business in two segments: Federal Education Loans, and Consumer Lending. A majority of its revenue is generated from the Federal Education Loans segment, in which the company owns and manages the Federal Family Education Loan Program (FFELP) loans, generating revenue mainly in the form of net interest income. The Consumer Lending segment owns and manages private education loans and is the master servicer for these portfolios. Through its Earnest brand, the company also refinances and originates in-school private educational loans.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.

Share on Social Networks: